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ABSTRACT
Loss of c-MYC is required for downregulation of
ribosomal RNA (rRNA) gene (rDNA) transcription
by RNA Polymerase I (Pol I) during granulocyte dif-
ferentiation. Here, we demonstrate a robust reduc-
tion of Pol I loading onto rDNA that along with a
depletion of the MYC target gene upstream binding
factor (UBF) and a switch from epigenetically active
to silent rDNA accompanies this MYC reduction.
We hypothesized that MYC may coordinate these
mechanisms via direct regulation of multiple compo-
nents of the Pol I transcription apparatus. Using
gene expression arrays we identified a ‘regulon’ of
Pol I factors that are both downregulated during
differentiation and reinduced in differentiated gran-
ulocytes upon activation of the MYC-ER transgene.
This regulon includes the novel c-MYC target
genes RRN3 and POLR1B. Although enforced MYC
expression during granulocyte differentiation was
sufficient to increase the number of active rRNA
genes, its activation in terminally differentiated
cells did not alter the active to inactive gene ratio
despite increased rDNA transcription. Thus, c-MYC
dynamically controls rDNA transcription during
granulocytic differentiation through the orchestrated
transcriptional regulation of core Pol I factors and
epigenetic modulation of number of active rRNA
genes.
INTRODUCTION
The complexity underlying the ability of the oncogene and
transcriptional regulator MYC to regulate growth stems
from its role in controlling ribosome biogenesis via tran-
scriptional mechanisms that include all three RNA poly-
merases (I, II and III) (1,2). Central to c-MYC’s role in
growth is its ability to regulate expression of the 45S ribo-
somal RNA (rRNA) precursor (45S rRNA), a key rate
limiting step of ribosome biogenesis that requires tran-
scription of a proportion of the approximately 200
copies of rRNA genes by RNA Polymerase I (Pol I) (3).
Intriguingly over 50% of the rRNA genes are transcrip-
tionally silent at any one time (4,5). Thus, theoretically
ribosomal gene (rDNA) transcription rate per cell can be
modulated by the rate of transcription per active rRNA
gene and/or the relative proportion of genes that are
epigenetically active or silent.
MYC has been implicated in controlling rDNA tran-
scription rate per gene through transcriptional control of
the Pol I transcription initiation upstream binding factor
(UBF) and through direct interaction of c-MYC with the
rDNA itself and rDNA associated factors in the nucleolus
(6–9). Intriguingly, in addition to transcription initiation,
*To whom correspondence should be addressed. Tel: +61 3 9656 1954; Fax: +61 3 9656 3717; Email: grant.mcarthur@petermac.org
Correspondence may also be addressed to Gretchen Poortinga. Tel: +61 3 9656 1279; Fax: +61 3 9656 1411; Email: gretchen.poortinga@
petermac.org
Correspondence may also be addressed to Ross Hannan. Tel: +61 3 9656 1747; Fax: +61 3 9656 1411; Email: ross.hannan@petermac.org
Present address:
Meaghan Wall, Victorian Cancer Cytogenetics Service, St Vincent’s Hospital, Fitzroy, Victoria, Australia
Nucleic Acids Research, 2010, 1–15
doi:10.1093/nar/gkq1205
 The Author(s) 2010. Published by Oxford University Press.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/
by-nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
 Nucleic Acids Research Advance Access published December 21, 2010
 at Peter M
acCallum
 Cancer Institute on January 17, 2011
n
a
r.o
xfordjournals.org
D
ow
nloaded from
 
we and others have shown that UBF also regulates active
ribosomal gene chromatin (r-chromatin) (10–12).
Speciﬁcally, through binding across the promoter and
entire coding region of the rRNA genes, UBF maintains
an open chromatin structure, most likely by displacing
linker histone (H1) (12,13). As UBF is a direct transcrip-
tional target of c-MYC these data suggest r-chromatin
remodeling is partially under the control of c-MYC.
However, the extent of MYC’s inﬂuence on rDNA
silencing is unknown and the mechanisms by which
MYC regulates rDNA transcription during dynamic and
biologically relevant processes such as differentiation are
poorly understood.
MYC is a transcription factor belonging to a family of
basic helix-loop-helix-zipper (bHLHZ) proteins that bind
as heterodimers to speciﬁc DNA sequences including the
canonical E-box sequence CACGTG located in target
gene promoters and much study has focused on iden-
tifying, analyzing and integrating the extensive cohort of
c-MYC target genes (14–17). Differentiation is a physio-
logical process that requires precise regulation of
MYC function and thus provides a context to study the
assimilation of fundamental MYC-driven gene pathways
and mechanisms including rDNA transcription (18).
Terminal granulocyte differentiation (TGD) is the
process whereby progenitor cells restricted to the granulo-
cytic lineage differentiate into mature neutrophils. Deﬁned
by their characteristic cell morphology, there are distinct
stages of TGD: proliferating myeloblasts mature into
promyelocytes then myelocytes followed by post-mitotic
metamyelocytes and ﬁnally polymorphonuclear neutro-
phils. In addition to exiting the cell cycle, cells undergoing
TGD exhibit a signiﬁcant loss in cellular mass which in
model systems of granulocyte differentiation occurs in a
c-MYC dependent manner as measured by several param-
eters including cell volume, rate of de novo protein synthe-
sis and 45S expression (6,19). A prerequisite for TGD is
downregulation of c-MYC expression and in fact enforced
expression of c-MYC blocks differentiation in several
systems (19–22). While c-MYC is an established regulator
of ribosome biogenesis, limited studies have investigated
MYC’s role in Pol I transcriptional regulation during
differentiation and much of our mechanistic under-
standing derives from studies carried out in static model
systems such as ﬁbroblasts (6–9,23). Interrogation of how
multiple MYC-dependent mechanisms of growth control
coalesce during a dynamic process such as differentiation
is crucial for our understanding of MYC function in a
disease setting.
Downregulation of MYC during granulocyte differen-
tiation leads to loss of UBF expression that correlates with
an increased proportion of silent rRNA genes and repres-
sion of rRNA synthesis (6,12). This suggests a model
where MYC controls rDNA transcription rates during
TGD through silencing of rRNA genes. However, our
data in mouse ﬁbroblasts and that in yeast experiments
(24,25) demonstrate that manipulating the number of
active rRNA genes does not necessarily lead to a propor-
tional change in cellular rRNA synthesis output.
Following UBF depletion in the ﬁbroblast model, while
the majority of rDNA genes were silenced, the rate of Pol I
transcription was maintained due to a compensatory
increase in the amount of Pol I associated with the remain-
ing active rDNA repeats (12). Thus, at least under some
conditions, rDNA silencing actually enhances the efﬁ-
ciency of rDNA transcription by concentrating Pol I
around fewer active genes. Therefore, during granulo-
cyte differentiation, although rDNA silencing may occur
concomitantly with the downregulation of Pol I transcrip-
tion, it is unlikely to be sufﬁcient to regulate rDNA
transcription rates.
In light of this, we have examined possible mechanisms
by which MYC regulates rDNA transcription during
differentiation using an in vitro model of TGD, the
MPRO (mouse promyelocyte) model (26). Through
expression proﬁling we have discovered that MYC regu-
lates almost the entire repertoire of Pol I subunits and
associated transcription factors. We show that members
of this gene set, hereafter referred to as a Pol I ‘regulon’,
are direct MYC target genes. Thus, as cells undergo differ-
entiation and MYC expression is switched off, expres-
sion of factors driving rDNA transcription are likewise
downregulated. Conversely, concomitant with the
upregulation of rDNA transcription, the regulon is
re-induced in differentiated MPRO cells upon activation
of the conditional MYC-ER fusion protein. These data
suggest a model whereby downregulation of rDNA tran-
scription in response to loss of MYC during differentiation
is modulated largely through reducing the availability
of Pol I and its associated transcription factors. This
serves to repress Pol I transcription in two ways: reducing
UBF expression leads to silencing of the rRNA genes;
critically however, expression of Pol I and its associated
factors must also be reduced to prevent the hyperactivation
of the remaining active rDNA repeats. Thus, during
TGD MYC functions to couple the relative proportion
of active rRNA genes with availability of the Pol I tran-
scription apparatus to ensure efﬁcient regulation of
rDNA transcription. Given the ubiquitous and essential
nature of MYC and rDNA transcription, we propose
that this coordinate regulation of active rRNA gene
number and Pol I component levels by MYC is a funda-
mental mechanism for controlling rDNA transcription in
mammalian cells.
MATERIALS AND METHODS
Cell culture and cell analyses
The MPRO cell line (26) was cultured [in DMEM con-
taining 20% fetal bovine serum (FBS) and BHK-HM5
conditioned media] and differentiated (in DMEM con-
taining 10% FBS and BHK-HM5 conditioned media) by
the addition of 106 M retinoid X receptor (RXR)-speciﬁc
agonist AGN194204 (hereafter referred to as AGN)
(Allergan, Irvine, CA, USA) as described in detail in ref.
(19). MPRO cells were transduced with the pBabe-MYC-
ER retrovirus (27) and MYC-ER was activated by
addition of 200 nM 4-hydroxytamoxifan (4-OHT) as pre-
viously described (19). For cell morphology 30 000 cells
were cytospun onto glass slides, air-dried, methanol
ﬁxed and stained with May-Grunwald Giemsa (MGG).
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Cell volume was determined using a Beckman Coulter Z2
instrument.
Psoralen crosslinking assay
Cells were lysed in NP-40 lysis buffer and nuclei recovered
and irradiated in the presence of 4,5, 80-trimethylpsoralen
(psoralen) (Sigma) with a 366-nmUV light box as described
previously (12). Genomic DNA was isolated and digested
with SalI, separated on a 0.9% agarose gel and alkaline
Southern blotting was performed. Psoralen cross-
linking was reversed and the membrane was hybridized
to a puriﬁed 32P-labelled rDNA probe (12). Finally, the
membrane was visualized on a PhosphoImager and
quantitated using ImageQuant (TLv2005.04) (both GE
Healthcare).
Western blotting
Immunoblotting was performed using 10–100 mg total
protein extracts lysed in sodium dodecyl sulfate (SDS)
lysis buffer and separated by SDS–PAGE as described
(19). For detection of the RRN3 protein, 2–5 107 D0
and D4 wt MPRO cells were harvested and S100
extracts were prepared as previously described (28).
Proteins were then transferred to polyvinylidene ﬂuoride
(PVDF) membranes and analyzed using the antisera listed
below and enhanced chemiluminescence. The antibodies
used were: anti-c-MYC (sc-764), anti-ERa (sc-542) and
anti-RRN3 (sc-11805, wtMPRO Western) (all obtained
from Santa Cruz Biotechnology, Santa Cruz, CA, USA);
anti-Actin (691002; MP Biomedicals, Solon, OH, USA);
anti-UBF1/2 and anti-POLR1B (128 kDa subunit) are
in-house polyclonal rabbit antisera (29); the polyclonal
rabbit anti-PAF53 and the polyclonal sheep anti-RRN3
(MYC-ER MPRO Western) antisera were kind gifts from
Prof. Lawrence I. Rothblum, Oklahoma City, Oklahoma
and Prof. Brian McStay, Galway, Ireland, respectively.
Quantitative chromatin immunoprecipitation assay
Quantitative chromatin immunoprecipitation (qChIP)
assays were carried out as described previously (6).
Crosslinking was achieved with 0.8% formaldehyde and
assays were performed using 1–5 107 cells per
immunoprecipitation (IP). ChIP antibodies used were:
anti-c-MYC, anti-UBF1/2 and anti-POLR1B (used for
western analysis); anti-trimethyl H3K4 (ab8580) and
anti-H4 (ab31827) (both from Abcam, Cambridge, MA,
USA); and anti-hyperacetylated H4 (06-946), anti-acetyl
H3K9 (07-352) and anti-H3 (07-690) (all from Upstate,
Millipore, Billerica, MA, USA). Control antisera for
ChIPs were normal rabbit IgG (sc-2027; Santa Cruz)
and in-house pre-immune rabbit serum. For all ChIPs,
5 mg of puriﬁed antibody or 10 ml of sera were used per
IP. Samples were analyzed in triplicate by quantitative
real-time PCR (qPCR) using the SYBR Green mix on
the StepOnePlusTM real-time PCR system (Applied
Biosystems). To calculate the percentage total DNA
bound, qPCR analyses of unprecipitated input samples
were used as reference for corresponding IPs. Final enrich-
ment was determined by subtracting appropriate control
IP values. Primer sequences used for rDNA ChIPs are
all previously published (12) except for the 28S and T2
amplicons that along with those from all other ChIP
amplicons are listed in Supplementary Table S1. ChIP-
CHOP assays were performed by digesting DNA
isolated from ChIPs with HpaII prior to qPCR and the
relative level of HpaII-resistance was calculated after
normalization to mock-digested DNA (12).
RNA isolation and gene expression analysis by
quantitative real-time RT–PCR
Total RNA was isolated from cells using TRIzol
(Invitrogen) and reverse transcribed by Superscript III
(Invitrogen) using random hexamers (Promega).
Real-time PCR was performed as for ChIP samples then
quantitated using the delta–delta CT (CT) method.
Primer sequences are either previously published (19) or
listed in Supplementary Table S1.
Gene expression proﬁling
Total RNA was extracted from samples derived from four
biological replicates using TRIzol and further puriﬁed
using the Qiagen RNeasy Mini kit (Qiagen). RNA
quality was assessed using the Agilent 2100
Electrophoresis Bioanalyzer and for each array 5 mg of
total RNA was used to prepare the target probe with
the Affymetrix One-Cycle Target Labeling reagents
(Affymetrix Inc., Santa Clara, CA, USA). Probes were
hybridized to Affymetrix Mouse Genome 430 2.0 arrays
according to the manufacturer’s instructions. Using
Bioconductor (30), the gene expression data was
imported into the statistical software suite R and follow-
ing quality assessment of the chips (31), the data was
normalizsed and background corrected using the robust
multi-array average (RMA) expression measure with the
help of probe sequence (gcRMA) (32). The package Affy
(33) was used to produce MAS5 calls and the Limma
package (34) was then used to model the data and assess
differential expression. For each probeset the average
log2-expression for each treatment was calculated and
pairwise comparisons performed. Any probesets that
had a log2-fold-change greater than 1 (corresponding to
a 2-fold change in expression level) and a false discovery
rate (FDR) adjusted P> 0.05 (35) were considered differ-
entially expressed. The expression array data are available
at www.ebi.ac.uk/arrayexpress under accession numbers
E-MEXP-2786 (wt MPRO) and E-MEXP-2794
(MYC-ER MPRO).
RESULTS
MYC levels equate with UBF binding to rDNA and active
rRNA gene number during TGD
To investigate the relationship between MYC regulation
of UBF and Pol I transcription during granulocyte differ-
entiation we utilized the MPRO model system where the
role of MYC in promoting cell growth and inhibiting dif-
ferentiation is well characterized (6,19). Parental MPROs
(wt MPROs) were examined at multiple stages of differ-
entiation (Figure 1A) during which time expression of
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Figure 1. MYC regulates the epigenetic status of rRNA genes during granulocyte differentiation. (A) Top: schematic of wt MPRO cells induced to
differentiate by addition of AGN. Proliferating cells (D0) are treated with AGN and re-characterized after 2 days (D2) and 4 days of differentiation
(D4). Middle: morphology of wt MPROs at the stages described above. Bar=15 mm. Bottom: mean cell volume (MCV) in femtoliters (ﬂ) for wt
MPROs at the above stages. Results are the mean±SEM from four independent experiments. *P< 0.05 and **P< 1.0 104 compared to D0.
(B) Top: nuclei were extracted from wt MPROs at D0, D2 and D4 and subjected to psoralen crosslinking followed by Southern blot analysis of
rDNA [representative analysis of previously published data (D0 and D4; 12)]. Middle: quantitated fractions of active and inactive ribosomal genes
from the above Southern blot. Bottom: expression of the 45S rRNA precursor by qRT–PCR using primers directed against the 50 externally and
internally transcribed spacers (ETS and ITS, respectively) and normalized to b-2 microglobulin (B2M) expression (n=4). *P< 0.005 and
**P< 5.0 108 compared to D0. (C) Schematic of a single murine rDNA repeat with the positions of qPCR amplicons indicated: promoter
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c-MYC and its target gene UBF are downregulated.
MPROs undergo stereotypic TGD over 4 days upon treat-
ment with the RXR-speciﬁc agonist AGN, progressing
from promyelocytes prior to treatment (D0), to predomin-
antly myelocytes/metamyelocytes at 2 days of AGN treat-
ment (D2) and ﬁnally to differentiated neutrophils after
4 days of AGN (D4) (Figure 1A, top). Examination of
the morphology of wt MPRO at D0, D2 and D4 revealed
the changes expected during murine TGD: the stained
cytoplasm appeared progressively paler as protein
synthesis decreased and there was increasing chromatin
condensation; by D4 segmenting nuclei had the distinctive
ring-shaped appearance of murine neutrophils (Figure 1A,
middle). Concurrently, wt MPROs displayed a typical
reduction in cell size of 40% by D4 (Figure 1A, bottom).
Active rRNA gene number can be measured by relative
crosslinking of psoralen, a DNA intercalating agent that
incorporates into open chromatin associated with nascent
rRNA transcripts but is inaccessible to silent genes
associated with regularly spaced nucleosomes. Following
psoralen crosslinking the active and inactive rRNA genes
can be distinguished by a Southern blot assay based on the
differing rates of migration of an rDNA SalI restriction
fragment (36,37). In the MPRO model the number of
active rRNA genes decreases during differentiation
(Figure 1B, top and middle) correlating with a signiﬁcant
decrease in expression of 45S rRNA (Figure 1B, bottom)
(6,12).
As regulation of active rRNA gene number occurs in a
UBF-dependent manner, we next proceeded to thoroughly
characterize UBF’s association with the rDNA repeat
during TGD. Utilizing primer sets for qPCR that amplify
rDNA sequences representing functional sites and domains
across the entire repeat, we performed qChIP analysis of
UBF occupancy in D0 and D4MPRO cells (Figure 1C and
previously described in 12). Other than theminimal binding
detected at the termination sequences (T1 and T2), UBF
was present at considerable levels across the entire rDNA
repeat in D0 cells and demonstrated an 50% decrease
in binding at all sites examined during differentiation
(Figure 1D, left). High levels of absolute UBF occupancy
are found at the proximal promoter UCE and CORE sites
(Figure 1D, left) which span a key regulatory CpG di-
nucleotide at 133 from the transcription start site (TSS)
that when methylated is minimally bound by UBF and
renders the rRNA gene transcriptionally silent (12,38).
The ChIP-CHOP assay (39), a method that determines
the methylation status of DNA isolated by ChIP assay
via digestion with the methylation sensitive restriction
enzyme HpaII followed by qPCR across the site, was per-
formed on DNA from UBF ChIP assays in proliferating
MPRO cells. ChIP-CHOP analysis revealed that UBF as-
sociates predominantly with active rRNA genes as
determined by the unmethylated status at the 133 CpG
dinucleotide of the majority of UBF bound rDNA (90%)
as compared to control rabbit serum bound rDNA (55%)
(Figure 1D, right). Therefore as absolute levels of UBF
protein decrease during TGD, the amount of UBF
associated with actively transcribed rDNA likewise de-
creases, ultimately coinciding with a reduction in the
number of active genes.
In addition to regulating levels of UBF, the MYC
protein has also been shown in several systems to
directly interact with the rDNA repeat, via both binding
E-boxes and protein–protein interactions with the SL-1
complex, and thus stimulate rRNA transcription (7–9).
To assay MYC binding to the rDNA repeat in gran-
ulocytes, qChIP analysis in D0 and D4 MPRO cells was
executed, assessing the same rDNA amplicons used
for UBF qChIP (Figure 1C) which also correspond with
canonical and non-canonical E-boxes. Notably, we
detected modest although statistically signiﬁcant enrich-
ment of MYC across the rDNA repeat in proliferating
granulocytes; absolute levels of MYC protein associated
with the rDNA repeat were approximately 7-fold lower
as compared with MYC binding at the UBF promoter,
a positive control for a MYC-regulated gene
(Supplementary Figure S1A).
We have observed a correlation between MYC-
dependent loss of UBF expression during MPRO
differentiaton and its depletion from the rDNA repeat
with an increase in the number of silent rRNA genes.
To address the question of whether c-MYC is capable of
driving changes in active rRNA gene number during
TGD, we employed an MPRO system with inducible
MYC activity. MPRO cells expressing the conditional
MYC-ER gene (MYC-ER MPROs) were harvested at
various stages of MPRO differentiation following activa-
tion of the MYC-ER fusion protein by addition of 4-OHT
(27,40) and then subjected to psoralen crosslinking to
determine the active versus inactive gene ratios. First, we
activated MYC-ER by the addition of 4-OHT prior to
initiating differentiation of MYC-ER MPROs with the
retinoid agonist and then assayed psoralen ratios after
2 days of differentiation. By D2, 4-OHT treated MPROs
undergoing a MYC-driven block to differentiation (19)
enhancer (ENH); proximal promoter sites of demonstrated factor binding including the upstream control element (UCE) and the core region
(CORE); 50 ETS amplicons (ETS1, 2 and 3); 50 ITS; the stably expressed 28S rRNA; and transcription termination sequences (T1 and 2).
E-boxes associated with amplicons are indicated with white boxes. (D) Left: qChIP analysis of UBF binding at rDNA sequences from (C).
Analysis was performed on cells harvested prior to AGN treatment (D0) and at D4 of differentiation where the percent (%) total DNA value
represents DNA enrichment with the anti-UBF antibody followed by subtraction of the control rabbit serum (RS) bound DNA (results from a
minimum of three independent experiments). *P< 0.05 and **P< 0.005 compared to D4. Right: ChIP-CHOP assay of UBF and RS ChIPs in D0
MPROs. DNA samples were both HpaII and mock digested prior to qRT–PCR analysis using the CORE primers to determine the relative fraction
of HpaII-resistant, methylated rDNA (METH) with the remaining fraction designated as unmethylated (UNMETH) (n=1). (E) MYC-ER MPROs
(D0) were induced to differentiate for 36 h (36h) before being treated with either vehicle control (EtOH) or 4-OHT for 24 h (60hE and 60hT,
respectively). Cells were harvested at indicated time points and protein lysates were analysed by Western blotting for expression of MYC-ER as
compared to Actin (top left) while nuclei were analysed by psoralen crosslinking assay (bottom left) as described in (B). The relative fractions of
active and inactive rRNA genes were quantitated and represented graphically (right) (n=3). *P< 0.05.
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maintained an active to inactive gene ratio similar to that
of D0 cells whereas the partially differentiated D2 vehicle
(EtOH) treated cells showed a majority of rDNA in the
inactive state (Supplementary Figure S2A). This MYC-
mediated failure to appropriately silence rRNA genes is
likely to occur, at least in part, through MYC’s mainten-
ance of UBF expression.
We next treated cells with AGN to initiate differenti-
ation before activating MYC-ER. After 60 h of differenti-
ation, control cells had an active to inactive gene ratio of
40:60% (Figure 1E). In contrast, inclusion of 4-OHT in
the media for the last 24 h of differentiation (added at
36 h) reversed the ratio of active to inactive genes from
45:55 at 36 h to 55:45% by 60 h (Figure 1E), consistent
with observed higher rates of rDNA transcription
(Supplementary Figure S2B). These data demonstrate
that in the context of TGD, MYC is able to regulate
silencing of rRNA genes, presumably indirectly through
control of UBF levels.
Gene expression proﬁling during TGD identiﬁes a set of
MYC regulated core Pol I regulatory genes
In 3T3 ﬁbroblasts, an increase in the number of silent
rRNA genes due to loss of UBF leads to a compensatory
increase in Pol I loading on the remaining active genes
that results in a net maintenance of rDNA transcription
rates (12). However, given that in the MPRO system 45S
rRNA expression decreases signiﬁcantly (Figure 1B), we
examined the relative binding of Pol I per active rRNA
gene in differentiating MPROs by qChIP using an
antibody recognizing the second largest Pol I subunit
(POLR1B) to determine if, in contrast to ﬁbroblasts,
TGD is associated with reduced loading of Pol I in
addition to changes in the number of active genes
(Figure 2A). Canvassing the entire repeat, ChIP assays
revealed a substantial depletion of Pol I across the
promoter enhancer (ENH) and transcribed region
(ETS1-3, ITS and 28S) by D4 of MPRO differentiation,
suggesting a reduction in Pol I complex loading that co-
incides with the decline in 45S rRNA levels (Figure 2A).
This observed reduction in Pol I occupancy throughout
the transcribed rDNA sequences is striking given that the
qChIP results were normalized to 50% decrease in active
gene number (Figure 2A). Thus, in contrast to ﬁbroblasts
where Pol I loading on the remaining active genes
increased in response to UBF depletion to maintain tran-
scription output, during TGD the remaining active rRNA
genes are also depleted of Pol I and in turn, rDNA tran-
scription is downregulated.
In light of this signiﬁcant decrease in Pol I apparatus
association with rDNA during TGD, we hypothesized
that in addition to UBF, MYC may coordinate the tran-
scriptional downregulation of multiple core Pol I machin-
ery components and thus render Pol I levels and its
recruitment to rDNA limiting for transcription. To
examine the entire repertoire of genes involved in Pol I
transcription as well as those genes speciﬁc to Pol II and
III, we conducted a global gene expression analysis where
we generated the intersecting gene list from those genes
with decreased expression during MPRO differentiation
and those with induced expression upon activation of
MYC in MPROs. To achieve the latter, we utilized the
MYC-ER MPROs that were differentiated (low endogen-
ous MYC expression) and then harvested both prior to
(D4) and following induction of MYC-ER expression by
the addition for 24 h of either 4-OHT (D5T) or EtOH
vehicle control (D5E) (Figure 2B) (6). Morphological
analysis of MYC-ER MPROs showed the characteristic
pale cytoplasm, condensed chromatin and ring-shaped
nuclei of terminally differentiated murine granulocytes
in both D4 and control D5E cells (Figure 2C, left and
top right) whereas a considerable number of D5T cells
appeared larger with an increased nuclear to cytoplasmic
ratio as well as darker cytoplasmic staining consistent
with an increased cytoplasmic ribosome content and
upregulation of protein synthesis (Figure 2C, bottom
right). We also conﬁrmed that activation of MYC-ER in
these differentiated cells leads to an approximately 2-fold
induction of 45S expression demonstrating that activation
of MYC-ER is sufﬁcient to stimulate rDNA transcription
(Figure 2D; 6).
Expression analysis was carried out for MPRO cell
populations and of the 22 839 genes detected by the gene
expression array, 1794 genes (7.9%) decreased in expres-
sion 2-fold or more from D0 to D4. Conversely, when
MYC-ER was induced in D4 MPROs, 1897 genes
(8.3%) increased in expression 2-fold or more from D5E
to D5T. The Venn diagram of these two categories
revealed that 1082 genes, or 60% of the genes that
decreased in expression from D0 to D4 were re-induced
with MYC-ER activation (D5T>D5E) (Figure 2E).
We next pre-deﬁned a consensus set of annotated genes
involved in Pol I transcription—termed a ‘regulon’—
comprising genes described in the literature as being
required for the formation of the Pol I pre-initiation
complex and we similarly deﬁned core factor regulons
for both Pol II and Pol III for comparison with the Pol
I regulon (Supplementary Figure S3) (41,42). To gen-
erate the regulons we also utilized Ingenuity Pathways
Analysis that identiﬁes gene networks based on a main-
tained database of known functional interactions, as
an independent tool. The gene expression array data
for Pol I regulon genes, MYC and its antagonist MAD1
(also known as MXD1) and the MYC target genes orni-
thine decarboxylase (ODC1) and cyclin D2 (CCND2) are
depicted in representational heatmaps (Figuer 2F). Gene
expression array signal intensities showed that expression
of 64% of Pol I regulon genes decrease by >2-fold in wt
MPROs and 79% of the Pol I regulon is likewise induced
when comparing 4-OHT treated MYC-ER MPROs
to EtOH treated cells (Supplementary Figure S3A).
Notably, the 79% of Pol I regulon genes with >2-fold
increased expression compares to 43% of Pol III regulon
genes and only 14% of Pol II regulon genes
(Supplementary Figure S3A–C).
Validation of gene expression data
Pol I transcription initiation requires a number of core
factors: initially UBF forms a complex with selectivity
factor 1 (SL-1, minimally comprised of TAF1A, B, C
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mean±SEM from a minimum of three independent experiments. *P< 0.05 and **P< 0.01 compared to D4. The total percentage ChIP values were
normalized to the average relative proportion of active genes for D0 (0.44) and D4 (0.19) MPROs as determined by psoralen crosslinking experi-
ments described here (Figure 1B) and in our previously published report (12). (B) Schematic of wt MPRO proliferating cells (D0) induced to
differentiate for 2 days (D2) and 4 days (D4). Differentiated MYC-ER MPROs (D4) were treated with EtOH vehicle or 4-OHT for 24 h (D5E and
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P< 0.05) between D5T and D5E. (F) Heatmaps of transcripts from Pol I regulon genes and MYC target genes ODC1 and CCND2 displaying a
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accordance with MYC expression. The MYC transcriptional antagonist MAD1/MXD1 shows an opposing expression pattern. The mean relative
expression levels are represented by a color scale where red, high; black, mean; and green, low expression.
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and D and TBP) at the rRNA gene promoter which in
turn allows for recruitment of transcriptionally competent
Pol I holoenzyme deﬁned by the presence of RRN3 (also
called TIF-1A) (5,41,42). The Pol I enzyme is a
multisubunit complex including core subunits such as
POLR1B and several Pol I associated factors such as
PAF53 (42). To validate that the observed gene expression
proﬁles of the Pol I regulon coincided with expression of
MYC, changes in gene and protein expression of a subset
of regulon factors—UBF, TAF1C, RRN3, PAF53 and
POLR1B—were evaluated by quantitative real-time
RT–PCR (qRT–PCR) and western blot analysis, respect-
ively. qRT–PCR expression proﬁles of the subset revealed
a tight correlation with their respective gene expression
array signal intensities and mirrored the reduction of
endogenous MYC while contrasting the increase in
MAD1 expression during TGD (Figure 3A and B);
likewise western blot analysis conﬁrmed that decreases in
expression also occurred at the protein level (Figure 3C).
Activation of MYC transcriptional activity in differen-
tiated MYC-ER MPROs treated with 4-OHT was con-
ﬁrmed by signal intensity and qRT–PCR data indicating
induction of CCND2 (Figure 3D) while induction of the
MYC-ER fusion protein was monitored by western blot
analysis (Figure 3E). The subset of Pol I factors showed
induced expression following the speciﬁc activation of
MYC in D5T MPROs as determined by qRT–PCR,
gene expression array and western analysis (POLR1B,
UBF and RRN3) (Figure 3E and F). Expression proﬁles
from both wt and MYC-ER MPROs did not show signiﬁ-
cant changes for TTF-1, a multifunctional protein
involved in Pol I transcription termination and recently
shown to have a role in the epigenetic regulation of
r-chromatin but not considered to be a basal Pol I tran-
scription initiation factor, illustrating the speciﬁcity of the
regulon (Figure 3B and F) (43,44). Thus, the uniformity of
data across all levels of gene expression—qRT–PCR,
signal intensity and protein—strongly validate the gene
expression array data sets and reinforce the co-regulatory
expression patterns we observe between c-MYC and core
Pol I transcription machinery.
UBF, RRN3 and POLR1B are direct transcriptional
c-MYC target genes
Given the strong correlation between expression of core
Pol I transcription factors and c-MYC in our model, we
investigated whether in addition to UBF, other members
of this regulon might also be direct MYC targets.
Scanning 2 kb both up- and downstream of the TSS of
select Pol I regulon genes for canonical (CACGTG) and
non-canonical (CATGTG) E-boxes we identiﬁed a
minimum of one E-box in the regulatory regions of all
ﬁve genes (Figure 4A).
We then examined the role of c-MYC in the direct regu-
lation of both RRN3 and POLR1B as representative of
the active Pol I transcription complex. The RRN3 tran-
script was rapidly induced (within 3 h) in 4-OHT treated
serum-starved NIH3T3 cells expressing the c-MYC-ER
fusion protein; induction occurred in cells treated with
cycloheximide, an inhibitor of protein synthesis, providing
evidence for direct regulation of RRN3 by MYC
(Supplementary Figure S4A). To further address the
question of direct, in vivo transcriptional regulation of
these genes by c-MYC, we performed qChIP analysis to
determine if MYC is physically associated with select
RRN3 and POLR1B promoter E-boxes (Figure 4A).
qChIP assays were carried out in D0 and D4 wt MPRO
cells, providing the contrast of high and low levels of en-
dogenous c-MYC protein respectively and overall, the
degree of MYC binding at both the RRN3 and POLR1B
promoters was similar if not greater to the levels of
MYC found at the positive control UBF promoter E-box
1 in proliferating MPROs (Figure 4B). Of the E-boxes
examined, the RRN3 promoter distal E-box (located
4 kb upstream of the TSS) and the POLR1B promoter
E-box1 were bound by lower, non-signiﬁcant levels of
MYC protein in D0 cells indicating selectivity for MYC
enrichment in the promoter regions (Figure 4B).
Several reports in recent years have begun to dissect
what constitutes a genomic region of bona ﬁde direct
MYC interaction at a target gene (45–47). From these
studies, one of the major chromatin marks to be
associated with MYC binding at transcriptionally poised
target promoters was trimethylated histone H3 at lysine 4
(H3K4me3) (45). To adjust for changes in nucleosomal
density during TGD we carried out a qChIP analysis of
total histones H3 and H4 at target gene E-boxes in D0 and
D4 cells and subsequently normalized all histone mark
ChIPs to respective total histone levels. Of note, we
observed a general increase in overall histone levels at
these sites, most likely due to chromatin condensation
occurring as the cells differentiated (Supplementary
Figure S5A). We next performed qChIP analysis using
an antibody that recognizes H3K4me3 and detected high
levels of enrichment speciﬁcally at E-boxes showing sig-
niﬁcant c-MYC occupancy, with H3K4me3 levels
decreasing moderately during differentiation after normal-
ization to H3 (Figure 4C, top). c-MYC recruits histone
acetylases to target gene promoters which in part
mediates activation of transcription via increased acetyl-
ation of multiple lysines on histones H3 and H4 (46,48).
Using antibodies that recognize acetylated histone H4
(H4ac) and acetylated histone H3 at lysine 9 (H3K9ac)
and again normalizing to total histone levels, qChIP
assays detected greater association of acetylated histones
at the MYC bound E-boxes in D0 than in D4 MPROs, the
reduction of their occupancy during differentiation con-
sistent with the parallel loss of MYC binding (Figure 4C,
middle and bottom). Taken together, these data reveal a
direct role for c-MYC in the transcriptional regulation of
RRN3 and POLR1B and given the correlating expression
and presence of E-boxes in regulatory regions of other
Pol I regulon members, they too are most likely directly
regulated by MYC.
c-MYC enables recruitment of the Pol I apparatus to the
rDNA repeat but does not alter the relative proportion of
active rRNA genes in terminally differentiated neutrophils
We have demonstrated that MYC can promote changes in
active gene number during TGD; in addition, we have
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Figure 3. Validation of the gene expression array data deﬁning a MYC regulated Pol I regulon. (A) Wt MPROs were harvested for RNA extraction
prior to differentiation (D0) and after 2 (D2) and 4 (D4) days of differentiation. qRT–PCR (top panels) and gene expression analysis (signal
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(F) MYC-ER cells were treated as described in (D) and qRT–PCR (top) and gene expression analysis (bottom) were performed to assay expression
of Pol I regulon members and TTF-1. All qRT–PCR data was normalized to B2M expression. Results for all graphed data are the mean±SEM
from four independent experiments.
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provided evidence that MYC is required for the mainten-
ance of expression of the Pol I regulon suggesting that as
MYC levels decline during TGD, the amount of available
Pol I complexes becomes limiting. Activation of MYC-ER
in differentiated MPRO cells leads to a greater than 2-fold
increase in 45S expression (Figure 2D) and a concomitant
induction of core Pol I transcription factors (Figure 3E
and F). Thus, these cells provide an ideal MYC gain-
of-function setting to investigate both modulation of
active rRNA gene number and levels of Pol I complex
associated with the rDNA repeat as potential mechanisms
of MYC-mediated regulation of 45S transcription in
the MPRO system. Following differentiation, D4
MPROs were exposed to 4-OHT for 24 h and subsequent
psoralen analysis showed that while these cells displayed
the typical shift from predominantly active rRNA genes at
D0 to inactive at D4, once differentiated the majority
of rRNA genes remained inactive despite activation of
MYC and induction of MYC targets including UBF, a
regulator of active rRNA gene number (Figures 3E, F
and 5A). We then carried out a qChIP analysis of UBF
and found that consistent with maintenance of a low
active to inactive gene ratio there was no signiﬁcant
change in the amount of UBF associated with the
rDNA repeat regardless of UBF protein induction by
MYC-ER (Figures 3E and 5B, left).
An alternative explanation for MYC stimulation of
rRNA transcription in differentiated MPROs is increased
recruitment of Pol I complexes to the rRNA gene
promoter via the observed c-MYC-ER induced expression
of the Pol I regulon (Figures 2F, 3E and F). We performed
qChIP analysis of Pol I in D5T MPROs and found that
the same rDNA regions displaying signiﬁcant binding by
Pol I in proliferating MPROs, e.g. the ETS1 and 2 sites,
likewise displayed a 2-fold or more increase in Pol I occu-
pancy compared with control D5E cells (Figure 5B, right).
Thus, while MYC induced 45S expression coincides with
an increased association of the core POLR1B subunit at
the rDNA repeat, the lack of enrichment of UBF or
changes in active rRNA gene number suggests that once
cells have terminally differentiated MYC mediates activa-
tion of rDNA transcription independent of alterations in
the number of active rRNA genes (Figure 5B).
DISCUSSION
The MYC proto-oncogene transcriptionally regulates a
growing list of genes representing most of the processes
that drive cellular growth (49,50). Central to this func-
tion is the ability of MYC to control transcription of
the ribosomal genes, one of the most fundamental rate-
limiting steps in growth control (3). What is less clear is
how MYC achieves control over rDNA transcription
with numerous mechanism being implicated, including
indirect control though MYC dependent transcrip-
tional regulation of the Pol I factors such as UBF, direct
mechanisms such as protein–protein interactions between
MYC and Pol I initiation factors and direct binding of
MYC to the rDNA repeat and ﬁnally, regulation of
rRNA precursor processing (6–9,23). In this study, we
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have examined the ability of MYC to control rDNA
transcription in a physiologically relevant model of
granulocyte differentiation where the programmed
downregulation of MYC expression as cells differentiate
is associated with a marked repression of rDNA
transcription.
We demonstrate that MYC controls rDNA transcrip-
tion during differentiation at two distinct levels. First,
through direct regulation of the chromatin remodeling
factor UBF, MYC regulates the number of rRNA gene
copies that have an open chromatin structure and are thus
transcriptionally active; second, we show that MYC
modulates the loading of Pol I onto the active pool of
rRNA genes by transcriptionally controlling the availabil-
ity of core components of the Pol I initiation complex.
Thus, MYC functions to balance the number of active
rRNA genes with levels of the Pol I transcription appar-
atus to ensure that loading of Pol I onto the rRNA genes
remains optimal and matches ongoing demand for rDNA
transcription. Thus, in the highly proliferative granulocyte
precursors, where demand for rDNA transcription is
high, elevated MYC levels ensure the number of transcrip-
tionally active ribosomal genes is maximal as is the avail-
ability of active Pol I. Conversely in terminally
differentiated neutrophils where the need for rRNA is
reduced, negligible MYC expression ensures the number
of transcriptionally active rRNA genes is low and the
availability of active Pol I is limiting. Lastly, we demon-
strate that induction of MYC is sufﬁcient to reactivate
expression of the Pol I regulon and rDNA transcription
in terminally differentiated cells even though its ability to
increase the number of active rRNA genes is lost. The
uncoupling of the ability of MYC to coordinate active
rRNA gene number and the level of Pol I suggests that
terminally differentiated cells have evolved a chromatin
status that ‘clamps’ Pol I transcription capacity at a
reduced range, possibly to prevent unwanted re-activation
of ribosome biogenesis which may be counter-productive
or even detrimental to non-dividing cells.
Myc regulation of r-chromatin via UBF
At any one time, over 50% of the 200 copies of rRNA
genes are transcriptionally silent due to methylation of
speciﬁc CpGs at promoter proximal regions (4,5). The
remaining 50% are unmethylated and transcriptionally
active as long as they are bound by UBF that functions
to maintain an open chromatin structure of the
unmethylated rRNA genes, most likely by displacing
linker H1 (51). Here we demonstrate that not only did
activation of MYC via a MYC-ER transgene prior to dif-
ferentiation prevent the decrease in active gene number
but also activation of MYC during differentiation
reversed the decrease in number of active genes. We
were unable to effectively deplete UBF protein for the
duration necessary to determine the extent of its require-
ment by MYC for modulation of active rRNA gene
number due to a strong selection against loss of UBF in
the highly proliferative MPROs. Nonetheless, this data
indicates that MYC regulates the proportion of active
rRNA genes at least in part through its ability to
transcriptionally control UBF levels and thus UBF
loading on the unmethylated rRNA genes and conse-
quently, in addition to its previously described roles in
regulation of rDNA transcription rate per gene, MYC
also controls chromatin remodeling of unmethylated
rRNA genes.
Myc regulation of a Pol I regulon
In other systems silencing of unmethylated rRNA genes
by depletion of UBF leads to a compensatory increase in
loading of Pol I on the remaining active genes, thus main-
taining rDNA transcription rates (12,24). In contrast,
during TGD, even accounting for the reduced number
of active rRNA genes, Pol I loading per gene in the
differentiated cells was dramatically lower than in undif-
ferentiated cells, suggesting that additional processes are
required to block increased Pol I loading onto the remain-
ing active rRNA genes. Our data demonstrate that the
most likely mechanism to account for this is that the avail-
ability of the Pol I transcription apparatus becomes
limiting for efﬁcient rDNA transcription. Expression
array analysis demonstrates that during differentiation a
suite of genes important for Pol I transcription are signiﬁ-
cantly downregulated. Furthermore our data strongly
implicate MYC in the regulation of this Pol I regulon as
reactivation of MYC in differentiated cells, where MYC
levels are normally low, led to induction of these genes.
In fact when Pol I-, II- and III- speciﬁc gene proﬁles were
examined the most signiﬁcant changes in gene expression
clustered with the Pol I regulon. Overall, induction of
MYC-ER in the differentiated MPROs coincided with a
2-fold or greater increase in expression of 1897 genes or
about 8% of genes represented on the gene expression
array chip. Over 79% of known Pol I-speciﬁc as
compared with only 14% of Pol II- speciﬁc factors were
upregulated in this setting. Furthermore, a selection of
Pol I regulon genes analyzed had one or more E-boxes
in their promoter proximal regions and for the two of
these tested, MYC directly bound the promoters by
qChIP analysis. Thus, we conclude that MYC transcrip-
tionally regulates the Pol I regulon during TGD to control
the level of Pol I factors available for efﬁcient transcrip-
tion. Interestingly, in the absence of E-boxes or direct
dMyc interaction at rRNA genes, an indirect role for
MYC regulation of Pol I factors was observed in
Drosophila (52). This reinforces that such modulation is
less likely to be critical for acute regulation of rDNA tran-
scription in response to ﬂux in growth factor signaling,
however during development and differentiation or when
new steady state levels of rDNA transcription need to be
established, controlling the level of available Pol I factors
provides an attractive mechanism to achieve sustainable
regulation of Pol I transcription.
Does MYC regulate Pol I by other mechanisms in
differentiating granulocytes?
While the availability of Pol l I factors are likely to be
important for Pol I loading, clearly additional regulatory
process such as histone modiﬁcations are also required to
facilitate efﬁcient Pol I transcription initiation. In this
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regard it is of interest to note that others have reported
data that MYC is able to regulate rDNA transcription by
interaction with the TBP containing SL-1 factor, direct
rDNA binding and more recently, via facilitation of
rDNA gene looping (7–9). In the MPRO differentiation
model absolute levels of endogenous MYC protein
associated with the rDNA repeat were considerably low
as compared with levels of MYC bound to the Pol II
regulated MYC target genes described in this study
(Figure 4B and compared with UBF in Supplementary
Figure S1A). While the consequence of this comparatively
low but statistically signiﬁcant level of MYC binding
at the rDNA repeat is unclear, the highest occupancy
of MYC was observed within the ETS region proximal
to the TSS and also in the transcription termination
region, regions similarly located to the amplicons
showing the highest c-MYC occupancy at the human
rDNA repeat (8). It is possible that the functional thresh-
old for MYC binding at the rDNA repeat is lower than
that at Pol II target genes where MYC transcriptional
activity can be regarded as relatively inefﬁcient (2). In
addition, this observed low-level association of endogen-
ous MYC at the rDNA repeat may mediate func-
tions other than acute transcriptional regulation, such
as effecting changes on the chromatin topography
associated with maintenance of the undifferentiated
state or facilitating assembly of the high levels of Pol I
components required for transcription. This last point
includes the ability of MYC to interact with SL-1
and assist its loading onto the rDNA repeat whereby
MYC itself, even at low occupancy, may be a component
of the Pol I machinery that becomes limiting during
TGD (8). Finally, there is emerging evidence that demon-
strates a role for MYC, particularly in the context
of maintaining cellular pluripotency (e.g. ES cells), in
the more generalized epigenetic regulation of chromatin
(53–55).
MYC coordinates active gene number with availability of
the Pol I apparatus to ensure long-term regulation of Pol
I transcription
An intriguing question that arises from our studies is why
differentiating cells have evolved a mechanism to silence
rRNA genes if it is not permanently sufﬁcient to
downregulate Pol I transcription. However, we propose
that the coordinated modulation of both active rRNA
gene number and levels of available Pol I apparatus are
essential to allow for efﬁcient downregulation of rDNA
transcription during differentiation. Firstly, a reduction
in number of active genes without concomitant reduction
in the level of Pol I could result in the hyperactivation
of remaining genes, with the net effect being sustained
high rDNA transcription levels not compatible with dif-
ferentiation. Conversely, a reduction in only the levels of
Pol I components without concomitant silencing of active
rRNA genes would lead to a large proportion of ‘open’
rRNA genes devoid of Pol I; recent studies by
Gagnon-Kugler et al. (56) suggest that this could lead to
their transcription by Pol II, an event shown to be cyto-
toxic to the cell. By coordinating these two processes, the
lower steady state levels of rRNA synthesis reﬂective of
differentiated granulocytes can be achieved while prevent-
ing incursion of Pol II into the Pol I locus or other poten-
tial detrimental effects associated with open r-chromatin
that is not undergoing active Pol I transcription.
Interestingly, coupling of the levels of active rRNA
genes and Pol I activity is not obligate as in the terminally
differentiated granulocytes, forced reactivation of MYC
no longer increases the number of active rRNA genes
although it does increase Pol I regulon levels, Pol I
loading onto rDNA repeats and rDNA transcription,
although to signiﬁcantly lower levels than those found in
the proliferating cells. This ‘lock’ on the inactive chroma-
tin state may provide cells with an assurance against erro-
neous hyperactivation of rDNA transcription that is
incompatible with the differentiated cell program. We
recently reported that methylation of a crucial regulatory
CpG di-nucleotide at 133 in the rRNA promoter
implicated in silencing of murine rRNA genes (38) and
shown to reduce UBF binding to the rRNA gene
promoter does not change during TGD in MPRO cells
(12). Thus, it does not appear that the inability of MYC
to increase the number of active repeats in differentiated
MPROs is regulated by methylation dependent silencing.
We have previously described this form of silencing,
termed pseudosilencing, in which UBF is unable to be
loaded onto rDNA independent of CpG methylation
(12). It may be the case that the repeat acquires other
chromatin marks, potentially acquired in the absence of
c-MYC’s epigenetic programming inﬂuences that prevent
the reversal of their inactive status.
In conclusion, we propose that MYC functions during
differentiation to coordinate the pool of active rRNA
genes with levels of Pol I factors to ensure the tight regu-
lation of rDNA transcription and ultimately ribosome
biogenesis to match cellular needs at any given stage. It
is interesting to speculate that MYC driven cancers
associated with deregulation of MYC might be associated
with proportionate increases in the number of active
rRNA genes and levels of Pol I factors which may
account for the hyperactivation of Pol I transcription
associated with these malignancies. Intriguingly, our
preliminary data demonstrate that MYC driven B-cell
lymphoma exhibit 5-fold increases in active rRNA gene
number that correlate with increased UBF expression and
UBF loading on active repeats (M. J. Bywater, manuscript
in preparation). We are currently investigating whether
MYC regulation of UBF and this observed increase in
active gene number contribute to the malignant process.
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